Nxera Pharma Co., Ltd.
4565.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥32,268 | ¥49,065 | ¥66,557 | ¥60,087 |
| Short-Term Investments | ¥3,935 | ¥0 | ¥0 | ¥86 |
| Receivables | ¥6,695 | ¥5,064 | ¥2,462 | ¥2,138 |
| Inventory | ¥8,838 | ¥2,903 | ¥32 | -¥33 |
| Other Curr. Assets | ¥6,119 | ¥8,080 | ¥891 | ¥530 |
| Total Curr. Assets | ¥57,855 | ¥65,112 | ¥69,942 | ¥62,808 |
| Property Plant & Equip (Net) | ¥7,468 | ¥7,900 | ¥3,791 | ¥3,817 |
| Goodwill | ¥25,693 | ¥24,623 | ¥15,306 | ¥15,095 |
| Intangibles | ¥51,911 | ¥52,291 | ¥8,577 | ¥9,120 |
| Long-Term Investments | ¥4,518 | ¥3,266 | ¥1,737 | ¥5,957 |
| Tax Assets | ¥4,021 | ¥3,964 | ¥806 | ¥86 |
| Other NC Assets | ¥32 | ¥42 | -¥742 | ¥102 |
| Total NC Assets | ¥93,643 | ¥92,086 | ¥29,475 | ¥34,177 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥151,498 | ¥157,198 | ¥99,417 | ¥96,985 |
| Liabilities | – | – | – | – |
| Payables | ¥4,052 | ¥4,244 | ¥1,628 | ¥1,176 |
| Short-Term Debt | ¥6,690 | ¥6,773 | ¥352 | ¥386 |
| Tax Payable | ¥255 | ¥378 | ¥260 | ¥279 |
| Deferred Revenue | ¥0 | ¥0 | ¥1,450 | ¥785 |
| Other Curr. Liab. | ¥4,635 | ¥5,790 | ¥402 | ¥4,565 |
| Total Curr. Liab. | ¥15,632 | ¥17,185 | ¥4,092 | ¥7,191 |
| LT Debt | ¥61,210 | ¥67,200 | ¥29,558 | ¥29,078 |
| Deferred Rev, NC | ¥3,776 | ¥3,882 | ¥4,791 | ¥384 |
| Deferred Tax Liab, NC | ¥1,857 | ¥1,490 | ¥2,922 | ¥2,706 |
| Other NC Liab. | ¥505 | ¥631 | ¥118 | ¥111 |
| Total NC Liab. | ¥67,348 | ¥73,203 | ¥37,389 | ¥32,326 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥4,375 | ¥4,817 | ¥1,753 | ¥1,831 |
| Total Liabilities | ¥82,980 | ¥90,388 | ¥41,481 | ¥39,517 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥47,172 | ¥46,807 | ¥41,335 | ¥41,036 |
| Retained Earnings | -¥20,942 | -¥16,104 | -¥8,911 | -¥9,768 |
| AOCI | ¥7,217 | ¥2,060 | -¥4,012 | -¥2,900 |
| Other Equity | ¥35,071 | ¥34,047 | ¥25,512 | ¥26,200 |
| Total Equity | ¥68,518 | ¥66,810 | ¥57,936 | ¥57,468 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥151,498 | ¥157,198 | ¥99,417 | ¥96,985 |
| Net Debt | ¥35,632 | ¥24,908 | -¥36,647 | -¥30,623 |